China Resources Boya Bio-pharmaceutical Group Co.,Ltd

SZSE:300294 Stock Report

Market Cap: CN¥15.4b

China Resources Boya Bio-pharmaceutical GroupLtd Dividends and Buybacks

Dividend criteria checks 3/6

China Resources Boya Bio-pharmaceutical GroupLtd is a dividend paying company with a current yield of 1.05%.

Key information

1.0%

Dividend yield

n/a

Buyback Yield

Total Shareholder Yieldn/a
Future Dividend Yield1.1%
Dividend Growth5.8%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareCN¥0.320
Payout ratio125%

Recent dividend and buyback updates

China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Is Increasing Its Dividend To CN¥0.30

Apr 26
China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Is Increasing Its Dividend To CN¥0.30

Recent updates

Investors Can Find Comfort In China Resources Boya Bio-pharmaceutical GroupLtd's (SZSE:300294) Earnings Quality

Nov 01
Investors Can Find Comfort In China Resources Boya Bio-pharmaceutical GroupLtd's (SZSE:300294) Earnings Quality

A Look At The Intrinsic Value Of China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294)

Oct 01
A Look At The Intrinsic Value Of China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294)

Market Participants Recognise China Resources Boya Bio-pharmaceutical Group Co.,Ltd's (SZSE:300294) Earnings

Sep 12
Market Participants Recognise China Resources Boya Bio-pharmaceutical Group Co.,Ltd's (SZSE:300294) Earnings

Does China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Have A Healthy Balance Sheet?

Jul 25
Does China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Have A Healthy Balance Sheet?

China Resources Boya Bio-pharmaceutical Group Co.,Ltd's (SZSE:300294) P/E Is On The Mark

Jun 12
China Resources Boya Bio-pharmaceutical Group Co.,Ltd's (SZSE:300294) P/E Is On The Mark

China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Is Increasing Its Dividend To CN¥0.30

Apr 26
China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Is Increasing Its Dividend To CN¥0.30

Is China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Using Too Much Debt?

Apr 22
Is China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Using Too Much Debt?

China Resources Boya Bio-pharmaceutical GroupLtd's (SZSE:300294) Conservative Accounting Might Explain Soft Earnings

Apr 01
China Resources Boya Bio-pharmaceutical GroupLtd's (SZSE:300294) Conservative Accounting Might Explain Soft Earnings

What Does The Future Hold For China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294)? These Analysts Have Been Cutting Their Estimates

Mar 31
What Does The Future Hold For China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294)? These Analysts Have Been Cutting Their Estimates

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 300294's dividend payments have been volatile in the past 10 years.

Growing Dividend: 300294's dividend payments have increased over the past 10 years.


Dividend Yield vs Market

China Resources Boya Bio-pharmaceutical GroupLtd Dividend Yield vs Market
How does 300294 dividend yield compare to the market?
SegmentDividend Yield
Company (300294)1.0%
Market Bottom 25% (CN)0.5%
Market Top 25% (CN)2.1%
Industry Average (Biotechs)1.2%
Analyst forecast (300294) (up to 3 years)1.1%

Notable Dividend: 300294's dividend (1.05%) is higher than the bottom 25% of dividend payers in the CN market (0.56%).

High Dividend: 300294's dividend (1.05%) is low compared to the top 25% of dividend payers in the CN market (2.17%).


Earnings Payout to Shareholders

Earnings Coverage: With its high payout ratio (124.7%), 300294's dividend payments are not well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonable cash payout ratio (65.5%), 300294's dividend payments are covered by cash flows.


Discover strong dividend paying companies